# Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

> **NCT02500316** · PHASE2 · COMPLETED · sponsor: **OPKO Health, Inc.** · enrollment: 48 (actual)

## Conditions studied

- Growth Hormone Deficiency (GHD)

## Interventions

- **DRUG:** MOD-4023

## Key facts

- **NCT ID:** NCT02500316
- **Lead sponsor:** OPKO Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2023-11
- **Final completion:** 2023-11
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02500316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02500316, "Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02500316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*